Do analysts prefer RDGT or ZCMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, RDGT or ZCMD?

Ridgetech has higher revenue and earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Zhongchao $11.38M 0.08 -$6.31M N/A N/A

Is RDGT or ZCMD more profitable?

Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Zhongchao N/A N/A N/A

Do analysts rate MEDS or ZCMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, MEDS or ZCMD?

Zhongchao has higher revenue and earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $8.02M 2.42 -$101.28M -$46.13 N/A Zhongchao $11.38M 0.08 -$6.31M N/A N/A

Is MEDS or ZCMD more profitable?

Zhongchao has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Wellgistics Health -1,100.16% N/A -171.81% Zhongchao N/A N/A N/A

Does the media prefer MEDS or ZCMD?

In the previous week, Wellgistics Health had 6 more articles in the media than Zhongchao. MarketBeat recorded 9 mentions for Wellgistics Health and 3 mentions for Zhongchao. Zhongchao's average media sentiment score of 0.51 beat Wellgistics Health's score of 0.17 indicating that Zhongchao is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wellgistics Health 0 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zhongchao 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ZCMD or IVF?

INVO Fertility has a consensus target price of $20.00, indicating a potential upside of 2,042.47%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts clearly believe INVO Fertility is more favorable than Zhongchao. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has stronger earnings & valuation, ZCMD or IVF?

Zhongchao has higher revenue and earnings than INVO Fertility. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zhongchao $11.38M 0.08 -$6.31M N/A N/A INVO Fertility $6.84M 0.34 -$25.13M -$33.83 N/A

Do analysts recommend ZCMD or NIVF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NewGenIvf Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, ZCMD or NIVF?

NewGenIvf Group has lower revenue, but higher earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zhongchao $11.38M 0.08 -$6.31M N/A N/A NewGenIvf Group $4.73M 0.35 $9.88M N/A N/A

Is ZCMD or NIVF more profitable?

Company Net Margins Return on Equity Return on Assets Zhongchao N/A N/A N/A NewGenIvf Group N/A N/A N/A

Does the media prefer ZCMD or NIVF?

In the previous week, Zhongchao and Zhongchao both had 3 articles in the media. NewGenIvf Group's average media sentiment score of 1.14 beat Zhongchao's score of 0.51 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zhongchao 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NewGenIvf Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ZCMD or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, ZCMD or HKPD?

Hong Kong Pharma Digital Technology has higher revenue and earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zhongchao $11.38M 0.08 -$6.31M N/A N/A Hong Kong Pharma Digital Technology $13.43M 0.10 -$1.14M N/A N/A

Is ZCMD or HKPD more profitable?

Company Net Margins Return on Equity Return on Assets Zhongchao N/A N/A N/A Hong Kong Pharma Digital Technology N/A N/A N/A

Zhongchao (ZCMD) Competitors

$0.77 +0.04 (+5.12%)

Closing price 04:00 PM Eastern

Extended Trading

$0.77 -0.01 (-0.94%)

As of 06:42 PM Eastern

Compare

ZCMD vs. RDGT, MEDS, IVF, NIVF, and HKPD

Should you buy Zhongchao stock or one of its competitors? Zhongchao's main competitors and comparable companies include Ridgetech (RDGT), Wellgistics Health (MEDS), INVO Fertility (IVF), NewGenIvf Group (NIVF), and Hong Kong Pharma Digital Technology (HKPD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Zhongchao compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

Ridgetech has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market. Comparatively, Zhongchao has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market.

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 1.7% of Zhongchao shares are held by institutional investors. 22.6% of Ridgetech shares are held by company insiders. Comparatively, 28.6% of Zhongchao shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Zhongchao had 2 more articles in the media than Ridgetech. MarketBeat recorded 3 mentions for Zhongchao and 1 mentions for Ridgetech. Ridgetech's average media sentiment score of 1.89 beat Zhongchao's score of 0.51 indicating that Ridgetech is being referred to more favorably in the media.

Company	Overall Sentiment
Ridgetech	Very Positive
Zhongchao	Positive

Ridgetech has higher revenue and earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Zhongchao	$11.38M	0.08	-$6.31M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Zhongchao	N/A	N/A	N/A

Summary

Ridgetech and Zhongchao tied by winning 4 of the 8 factors compared between the two stocks.

How does Zhongchao compare to Wellgistics Health?

Wellgistics Health (NASDAQ:MEDS) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

Zhongchao has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
Zhongchao	N/A	N/A	N/A

Zhongchao has higher revenue and earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$8.02M	2.42	-$101.28M	-$46.13	N/A
Zhongchao	$11.38M	0.08	-$6.31M	N/A	N/A

In the previous week, Wellgistics Health had 6 more articles in the media than Zhongchao. MarketBeat recorded 9 mentions for Wellgistics Health and 3 mentions for Zhongchao. Zhongchao's average media sentiment score of 0.51 beat Wellgistics Health's score of 0.17 indicating that Zhongchao is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wellgistics Health	0 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zhongchao	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

5.7% of Wellgistics Health shares are owned by institutional investors. Comparatively, 1.7% of Zhongchao shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by insiders. Comparatively, 28.6% of Zhongchao shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Wellgistics Health has a beta of -1.77, indicating that its stock price is 277% less volatile than the broader market. Comparatively, Zhongchao has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market.

Summary

Zhongchao beats Wellgistics Health on 7 of the 10 factors compared between the two stocks.

How does Zhongchao compare to INVO Fertility?

Zhongchao (NASDAQ:ZCMD) and INVO Fertility (NASDAQ:IVF) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

In the previous week, Zhongchao had 1 more articles in the media than INVO Fertility. MarketBeat recorded 3 mentions for Zhongchao and 2 mentions for INVO Fertility. Zhongchao's average media sentiment score of 0.51 beat INVO Fertility's score of 0.44 indicating that Zhongchao is being referred to more favorably in the media.

Company	Overall Sentiment
Zhongchao	Positive
INVO Fertility	Neutral

1.7% of Zhongchao shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 28.6% of Zhongchao shares are owned by insiders. Comparatively, 0.4% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Zhongchao has a beta of -0.04, indicating that its share price is 104% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.34, indicating that its share price is 134% more volatile than the broader market.

Zhongchao has higher revenue and earnings than INVO Fertility.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38M	0.08	-$6.31M	N/A	N/A
INVO Fertility	$6.84M	0.34	-$25.13M	-$33.83	N/A

INVO Fertility has a consensus target price of $20.00, indicating a potential upside of 2,042.47%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts clearly believe INVO Fertility is more favorable than Zhongchao.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Zhongchao has a net margin of 0.00% compared to INVO Fertility's net margin of -116.29%. Zhongchao's return on equity of 0.00% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
INVO Fertility	-116.29%	-85.54%	-31.05%

Summary

Zhongchao beats INVO Fertility on 8 of the 14 factors compared between the two stocks.

How does Zhongchao compare to NewGenIvf Group?

Zhongchao (NASDAQ:ZCMD) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

Zhongchao has a beta of -0.04, meaning that its share price is 104% less volatile than the broader market. Comparatively, NewGenIvf Group has a beta of -0.02, meaning that its share price is 102% less volatile than the broader market.

1.7% of Zhongchao shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 28.6% of Zhongchao shares are held by insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
NewGenIvf Group	N/A	N/A	N/A

In the previous week, Zhongchao and Zhongchao both had 3 articles in the media. NewGenIvf Group's average media sentiment score of 1.14 beat Zhongchao's score of 0.51 indicating that NewGenIvf Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zhongchao	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NewGenIvf Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NewGenIvf Group has lower revenue, but higher earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38M	0.08	-$6.31M	N/A	N/A
NewGenIvf Group	$4.73M	0.35	$9.88M	N/A	N/A

Summary

NewGenIvf Group beats Zhongchao on 6 of the 7 factors compared between the two stocks.

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Zhongchao (NASDAQ:ZCMD) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

1.7% of Zhongchao shares are owned by institutional investors. 28.6% of Zhongchao shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Zhongchao has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, indicating that its stock price is 123% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hong Kong Pharma Digital Technology has higher revenue and earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38M	0.08	-$6.31M	N/A	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.10	-$1.14M	N/A	N/A

In the previous week, Zhongchao had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 3 mentions for Zhongchao and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.44 beat Zhongchao's score of 0.51 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Zhongchao	Positive
Hong Kong Pharma Digital Technology	Positive

Summary

Hong Kong Pharma Digital Technology beats Zhongchao on 5 of the 8 factors compared between the two stocks.

Get Zhongchao News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZCMD vs. The Competition

Export

Metric	Zhongchao	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$898K	$9.84B	$7.19B	$14.92B
Dividend Yield	N/A	2.61%	2.57%	11.71%
P/E Ratio	N/A	34.18	274.09	25.35
Price / Sales	0.08	4.99	697.83	112.39
Price / Cash	N/A	126.25	77.71	51.48
Price / Book	0.00	5.33	10.37	6.25
Net Income	-$6.31M	$313.45M	$3.49B	$358.55M
7 Day Performance	-12.10%	3.22%	-1.78%	-2.07%
1 Month Performance	-22.57%	-0.42%	-1.48%	-4.80%
1 Year Performance	-99.91%	17.09%	18.20%	5.44%

Zhongchao Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZCMD Zhongchao	0.496 of 5 stars	$0.77 +5.1%	N/A	-99.9%	$898K	$11.38M	N/A	140	Short Interest Increase Gap Up
RDGT Ridgetech	1.0459 of 5 stars	$0.87 -4.2%	N/A	-99.6%	$3.30M	$132.16M	N/A	980	Gap Up
MEDS Wellgistics Health	0.356 of 5 stars	$0.87 -4.9%	N/A	-97.6%	$2.93M	$23.34M	N/A	31	News Coverage Gap Up Trading Halted
IVF INVO Fertility	1.9452 of 5 stars	$0.98 -0.3%	$20.00 +1,936.2%	-97.6%	$2.47M	$6.84M	N/A	10	Short Interest Increase
NIVF NewGenIvf Group	2.905 of 5 stars	$1.11 -2.6%	N/A	-99.9%	$2.40M	$4.73M	N/A	N/A	News Coverage Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZCMD) was last updated on 9/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zhongchao (ZCMD) Competitors

ZCMD vs. RDGT, MEDS, IVF, NIVF, and HKPD

How does Zhongchao compare to Ridgetech?

Summary

How does Zhongchao compare to Wellgistics Health?

Summary

How does Zhongchao compare to INVO Fertility?

Summary

How does Zhongchao compare to NewGenIvf Group?

Summary

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZCMD vs. The Competition

Zhongchao Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zhongchao (ZCMD) Competitors

ZCMD vs. RDGT, MEDS, IVF, NIVF, and HKPD

How does Zhongchao compare to Ridgetech?

Which has more volatility and risk, RDGT or ZCMD?

Do insiders and institutionals believe in RDGT or ZCMD?

Does the media favor RDGT or ZCMD?

Which has preferable earnings & valuation, RDGT or ZCMD?

Do analysts prefer RDGT or ZCMD?

Is RDGT or ZCMD more profitable?

Summary

How does Zhongchao compare to Wellgistics Health?

Is MEDS or ZCMD more profitable?

Which has preferable valuation & earnings, MEDS or ZCMD?

Does the media prefer MEDS or ZCMD?

Do analysts rate MEDS or ZCMD?

Do insiders and institutionals hold more shares of MEDS or ZCMD?

Which has more risk and volatility, MEDS or ZCMD?

Summary

How does Zhongchao compare to INVO Fertility?

Does the media favor ZCMD or IVF?

Do institutionals and insiders have more ownership in ZCMD or IVF?

Which has more risk & volatility, ZCMD or IVF?

Which has stronger earnings & valuation, ZCMD or IVF?

Do analysts recommend ZCMD or IVF?

Is ZCMD or IVF more profitable?

Summary

How does Zhongchao compare to NewGenIvf Group?

Which has more volatility and risk, ZCMD or NIVF?

Do institutionals and insiders believe in ZCMD or NIVF?

Is ZCMD or NIVF more profitable?

Does the media prefer ZCMD or NIVF?

Do analysts recommend ZCMD or NIVF?

Which has stronger valuation & earnings, ZCMD or NIVF?

Summary

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Is ZCMD or HKPD more profitable?

Do institutionals & insiders believe in ZCMD or HKPD?

Which has more volatility & risk, ZCMD or HKPD?

Do analysts prefer ZCMD or HKPD?

Which has higher valuation and earnings, ZCMD or HKPD?

Does the media prefer ZCMD or HKPD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZCMD vs. The Competition

Zhongchao Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools